Company
Logos Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Expedition Therapeutics | Series B | 2026-08-05 | |
| Pinnacle Medicines | Series B | 2026-03-26 | |
| Diagonal Therapeutics | Series B | 2026-01-09 | |
| Beacon Biosignals | Series B | 2025-11-13 | |
| Expedition Therapeutics | Series A | 2025-10-10 | Lead |
| 858 Therapeutics | Series B Financing | 2024-09-27 | |
| Attovia Therapeutics | series b | 2024-05-10 | |
| Rapport Therapeutics | Series B Funding | 2023-08-23 | Lead |
| Septerna | Series B Financing | 2023-07-17 | |
| Boundless Bio | Series C Financing | 2023-05-16 | |
| Odyssey Therapeutics | Series B | 2022-10-13 |